Replies to post #206789 on Biotech Values

[biomaven0]

I really don't think you need anything more to explain the sector moves than the Trump statements plus the momentum traders.

The threat of drawing Trump's attention will certainly concentrate the minds of the industry - so expect high profile pricing increases to be a thing of the past. Trump would like nothing more than to have some company rescind a price increase after he tweeted about it.

REGN to date the best behaved by far on pricing of a high priced drug (Eylea).